SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K May 13, 2021 8-K
10-Q May 13, 2021 10-Q
EFFECT Apr 29, 2021
CORRESP Apr 27, 2021
DEFA14A Apr 26, 2021 DEFA14A
DEF 14A Apr 23, 2021 DEF 14A
UPLOAD Apr 21, 2021
S-3 Apr 16, 2021 FORM S-3
8-K Mar 23, 2021 8-K
10-K Mar 23, 2021 10-K
4 Mar 8, 2021 OWNERSHIP DOCUMENT
4 Mar 8, 2021 OWNERSHIP DOCUMENT
4 Mar 8, 2021 OWNERSHIP DOCUMENT
4 Mar 8, 2021 OWNERSHIP DOCUMENT
4 Mar 8, 2021 OWNERSHIP DOCUMENT
4 Mar 8, 2021 OWNERSHIP DOCUMENT
4 Mar 8, 2021 OWNERSHIP DOCUMENT
SC 13G/A Feb 16, 2021 SC 13G/A
SC 13G/A Feb 12, 2021
8-K Feb 4, 2021 FORM 8-K
8-K/A Jan 28, 2021 FORM 8-K/A
8-K Jan 14, 2021 FORM 8-K
8-K Dec 23, 2020 FORM 8-K
424B5 Dec 14, 2020 424B5
SC 13G/A Dec 14, 2020 AMENDMENT TO FORM SC 13G
← Newer Page 10 of 51 · 1272 filings Older →